Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May;33(5):3222-3231.
doi: 10.1007/s00330-022-09346-6. Epub 2023 Jan 14.

Validation of a semi-automatic method to measure total liver volumes in polycystic liver disease on computed tomography - high speed and accuracy

Affiliations

Validation of a semi-automatic method to measure total liver volumes in polycystic liver disease on computed tomography - high speed and accuracy

Sophie E Aapkes et al. Eur Radiol. 2023 May.

Abstract

Objectives: Polycystic liver disease (PLD) is characterized by growth of hepatic cysts, causing hepatomegaly. Disease severity is determined using total liver volume (TLV), which can be measured from computed tomography (CT). The gold standard is manual segmentation which is time-consuming and requires expert knowledge of the anatomy. This study aims to validate the commercially available semi-automatic MMWP (Multimodality Workplace) Volume tool for CT scans of PLD patients.

Methods: We included adult patients with one (n = 60) or two (n = 46) abdominal CT scans. Semi-automatic contouring was compared with manual segmentation, using comparison of observed volumes (cross-sectional) and growth (longitudinal), correlation coefficients (CC), and Bland-Altman analyses with bias and precision, defined as the mean difference and SD from this difference. Inter- and intra-reader variability were assessed using coefficients of variation (CV) and we assessed the time to perform both procedures.

Results: Median TLV was 5292.2 mL (IQR 3141.4-7862.2 mL) at baseline. Cross-sectional analysis showed high correlation and low bias and precision between both methods (CC 0.998, bias 1.62%, precision 2.75%). Absolute volumes were slightly higher for semi-automatic segmentation (manual 5292.2 (3141.4-7862.2) versus semi-automatic 5432.8 (3071.9-7960.2) mL, difference 2.7%, p < 0.001). Longitudinal analysis demonstrated that semi-automatic segmentation accurately measures liver growth (CC 0.908, bias 0.23%, precision 4.04%). Inter- and intra-reader variability were small (2.19% and 0.66%) and comparable to manual segmentation (1.21% and 0.63%) (p = 0.26 and p = 0.37). Semi-automatic segmentation was faster than manual tracing (19 min versus 50 min, p = 0.009).

Conclusions: Semi-automatic liver segmentation is a fast and accurate method to determine TLV and liver growth in PLD patients.

Key points: • Semi-automatic liver segmentation using the commercially available MMWP volume tool accurately determines total liver volume as well as liver growth over time in polycystic liver disease patients. • This method is considerably faster than manual segmentation through the use of Hounsfield unit settings. • We used a real-life CT set for the validation and showed that the semi-automatic tool measures accurately regardless of contrast used for the CT scan or not, presence of polycystic kidneys, liver volume, and previous invasive treatment for polycystic liver disease.

Keywords: Organ size; Polycystic kidney disease; Polycystic liver disease; Radiology; Tomography, X-ray computed.

PubMed Disclaimer

Conflict of interest statement

The authors of this manuscript declare relationships with the following companies: Dr. Drenth has received grant support from Abbvie and Gilead. Dr. Gansevoort received grant support and fees for serving on advisory boards and steering committees from Galapagos, IPSEN, Otsuka Pharmaceuticals, and Sanofi-Genzyme. In addition, Dr. Gansevoort holds the Orphan Medicinal Product Designation status at the European Medicines Agency for lanreotide as treatment for kidney function decline in ADPKD (EMA/OD/027/15). All money is paid to their institutions. No other potential conflict of interest relevant to this article was reported.

No grants have a relation with the current study.

Figures

Fig. 1
Fig. 1
Flowchart of included patients and scans
Fig. 2
Fig. 2
Image of the segmentation tools. A Unsegmented slice. B Manual segmentation with Analyze. C Manual segmentation with Pinnacle. D Semi-automatic segmentation. E Segmentation with Syngo.Via
Fig. 3
Fig. 3
Bland-Altman plots of cross-sectional TLV measurement, compared between manual tracing and semi-automatic measurement. The solid line represents the reference and the dotted lines the bias and LoA. TLV, total liver volume; LoA, limits of agreement
Fig. 4
Fig. 4
Bland-Altman plots of total liver growth between the first and second CT scans, compared between manual tracing and volume measurement. The solid line represents the reference and the dotted lines the bias and LoA. TLV, total liver volume; LoA, limits of agreement

References

    1. Van Aerts RMM, Van De Laarschot LFM, Banales JM, Drenth JPH. Clinical management of polycystic liver disease. J Hepatol. 2018;68:827–837. doi: 10.1016/j.jhep.2017.11.024. - DOI - PubMed
    1. Cnossen WR, Drenth JPH. Polycystic liver disease: an overview of pathogenesis, clinical manifestations and management. Orphanet J Rare Dis. 2014;9:69–82. doi: 10.1186/1750-1172-9-69. - DOI - PMC - PubMed
    1. Cornec-Le Gall E, Alam A, Perrone RD. Autosomal dominant polycystic kidney disease. Lancet. 2019;393:919–935. doi: 10.1016/S0140-6736(18)32782-X. - DOI - PubMed
    1. Wijnands TFM, Neijenhuis MK, Kievit W, et al. Evaluating health-related quality of life in patients with polycystic liver disease and determining the impact of symptoms and liver volume. Liver Int. 2014;34:1578–1583. doi: 10.1111/liv.12430. - DOI - PubMed
    1. Temmerman F, Dobbels F, Ho TA, et al. Development and validation of a polycystic liver disease complaint-specific assessment (POLCA) J Hepatol. 2014;61:1143–1150. doi: 10.1016/j.jhep.2014.06.024. - DOI - PubMed

Supplementary concepts